CAGGIU, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 352
EU - Europa 219
AS - Asia 141
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 715
Nazione #
US - Stati Uniti d'America 349
CN - Cina 93
UA - Ucraina 80
IT - Italia 50
DE - Germania 31
SG - Singapore 29
FR - Francia 25
SE - Svezia 12
FI - Finlandia 10
KR - Corea 7
GB - Regno Unito 5
IN - India 4
BE - Belgio 3
CA - Canada 3
HK - Hong Kong 2
IR - Iran 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
IL - Israele 1
JP - Giappone 1
Totale 715
Città #
Chandler 100
Jacksonville 50
Princeton 27
Singapore 25
Dearborn 23
Sassari 20
Nanjing 19
Wilmington 18
New York 12
Beijing 8
Ashburn 7
Nanchang 7
Seoul 7
Changsha 6
Jiaxing 6
Norwalk 6
Shenyang 6
Mountain View 5
Cagliari 4
Hangzhou 4
Brussels 3
Guangzhou 3
Hebei 3
Helsinki 3
Jinan 3
Ningbo 3
Rome 3
San Mateo 3
Santa Clara 3
Tianjin 3
Ann Arbor 2
Boardman 2
Frankfurt am Main 2
London 2
Munich 2
Olbia 2
Shanghai 2
St Louis 2
Taizhou 2
Toronto 2
Zhengzhou 2
Alghero 1
Ardabil 1
Brno 1
Central 1
Fuzhou 1
Hefei 1
Huizhou 1
Hyderabad 1
Izmir 1
Madrid 1
Milan 1
Monmouth Junction 1
Ottawa 1
Quartu Sant'elena 1
San Francisco 1
Shenzhen 1
Sydney 1
Torino 1
Vienna 1
Woodbridge 1
Wuhu 1
Totale 433
Nome #
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 67
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 63
Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case-control study 63
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 63
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients 59
Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis Patients 59
High levels of antibodies against PtpA and PknG secreted by Mycobacterium avium ssp. paratuberculosis are present in neuromyelitis optica spectrum disorder and multiple sclerosis patients 55
Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease 54
Is there a role for Mycobacterium avium subspecies paratuberculosis in Parkinson's disease? 51
Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease? 49
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 49
Mycobacterium avium subsp. paratuberculosis and associated risk factors for inflammatory bowel disease in Iranian patients 48
Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients 45
Parkinson's disease: Immune System, infections and Alpha-synuclein protein 29
Totale 754
Categoria #
all - tutte 4.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202099 0 0 0 0 14 20 22 6 14 8 15 0
2020/2021111 13 0 15 0 14 2 13 5 16 16 12 5
2021/202278 7 2 0 2 0 0 2 7 9 6 17 26
2022/2023173 13 19 10 24 19 26 0 16 27 1 5 13
2023/202463 9 4 2 1 12 11 0 9 0 2 10 3
2024/202569 3 0 27 29 10 0 0 0 0 0 0 0
Totale 754